The US Food and Drug Administration (FDA) recently sent warning letters to two facilities in the United States and Mexico for ...
Data integrity is an ongoing concern across all R&D organizations, no matter what part of the research lifecycle they’re navigating. These concerns extend beyond the potential for delayed timelines or ...
The US Food and Drug Administration’s (FDA) interest in rooting out data integrity deficiencies among Indian pharmaceutical manufacturers continued this month with a warning letter issued to Hyderabad ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results